Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Lymphoma, High-grade”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00058292
What this trial is testing

Radiolabeled Monoclonal Antibody Therapy and High-Dose Chemotherapy Followed By Autologous Peripheral Stem Cell Transplant in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Northwestern University 44
Not applicableActive Not RecruitingNCT03656835
What this trial is testing

Nanochip Technology in Monitoring Treatment Response and Detecting Relapse in Participants With Diffuse Large B-Cell Lymphoma

Who this might be right for
Diffuse Large B-Cell LymphomaDiffuse Large B-Cell Lymphoma Germinal Center B-Cell TypeDiffuse Large B-Cell Lymphoma, Not Otherwise Specified+1 more
Ohio State University Comprehensive Cancer Center 73
Testing effectiveness (Phase 2)Study completedNCT00056966
What this trial is testing

Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation of Patients With Hematological Diseases

Who this might be right for
Hematologic Malignancy
Baylor College of Medicine 24
Early research (Phase 1)Looking for participantsNCT07225439
What this trial is testing

Rituximab (Rtx) + Tafasitamab in Combination With Allogeneic NK Cells for Treatment of Relapsed/Refractory (r/r) B-cell Non-Hodgkin Lymphoma (NHL)

Who this might be right for
Non Hodgkin LymphomaB-cell Non Hodgkin LymphomaDiffuse Large B Cell Lymphoma+7 more
Paolo Caimi, MD 15
Testing effectiveness (Phase 2)Ended earlyNCT02983097
What this trial is testing

Therapy of Non-Hodgkin-Lymphoma by Combination of Lenalidomide + Rituximab, Dexa, High-dose ARA-C and CisP

Who this might be right for
Diffuse Large B-cell Lymphoma (DLBCL)Follicular Lymphoma Grade III (FL III°)Mantle Cell Lymphoma (MCL), Blastoid Variant+2 more
Gesellschaft fur Medizinische Innovation - Hamatologie und Onkologie mbH 34
Not applicableStudy completedNCT06234280
What this trial is testing

Korean Multicenter Registry of ELUVIA Stent for Femoropopliteal Artery Disease

Who this might be right for
Symptomatic Peripheral Artery Disease With Femoropopliteal LesionsModerate or Severe Claudication (Rutherford Category 2 or 3)Critical Limb Ischemia (Rutherford Category 4 or 5)
Yonsei University 100
Testing effectiveness (Phase 2)Study completedNCT01958996
What this trial is testing

Phase I/II Study of Escalating Doses of Idarubicin Orally Given With Oral Cyclophosphamide, Etoposide, Prednisolone and Intravenous Rituximab in Elderly Patient With Disseminated High Grade Non Hodgkin Lymphoma

Who this might be right for
High Grade Lymphomas CD20 Positive
Poitiers University Hospital 27
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07774234
What this trial is testing

Sonrotoclax, Glofitamab, Gemcitabine, and Oxaliplatin for Relapsed or Refractory Large B-Cell Lymphoma

Who this might be right for
Large B-Cell Lymphoma (LBCL)High-grade B-cell Lymphoma
The First Affiliated Hospital of Soochow University 39
Not applicableEnded earlyNCT00987428
What this trial is testing

Early Endoscopic Ultrasound - Based Sphincterotomy or Conservative Treatment in Severe Biliary Pancreatitis

Who this might be right for
Pancreatitis Acute Biliary
Assistance Publique - Hôpitaux de Paris 27
Not applicableStudy completedNCT04902092
What this trial is testing

Brain Exercise and Addiction Trial

Who this might be right for
Cannabis Use Disorder, ModerateCannabis Use Disorder, Severe
Monash University 65
Testing effectiveness (Phase 2)Ended earlyNCT00143884
What this trial is testing

Study of Low Intensity Conditioning and Immunotherapy for High-Risk Cancers of the Blood

Who this might be right for
LeukemiaLymphoma, Low-GradeLymphoma, Non-Hodgkin's+2 more
University of Michigan Rogel Cancer Center 30
Testing effectiveness (Phase 2)UnknownNCT02061800
What this trial is testing

CD34+ (Malignant) Stem Cell Selection for Patients Receiving Allogenic Stem Cell Transplant

Who this might be right for
Chronic Myeloid Leukemia (CML)Acute Myelogenous Leukemia (AML)Myelodysplastic Syndrome (MDS)+3 more
Diane George 14
Testing effectiveness (Phase 2)Looking for participantsNCT07042438
What this trial is testing

Fecal Microbiome Transplant to Remodel Intestinal Microbiota for Patients With Relapsed or Refractory Lymphoma With Exposure to High-Risk Antibiotics Who Are Receiving Chimeric Antigen Receptor T Cells

Who this might be right for
Recurrent Diffuse Large B-Cell LymphomaRecurrent High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 RearrangementsRecurrent Transformed Follicular Lymphoma to Diffuse Large B-Cell Lymphoma+3 more
City of Hope Medical Center
Large-scale testing (Phase 3)Study completedNCT01313221
What this trial is testing

Efficacy and Safety of Etanercept 50 mg Once Weekly Plus As Needed Topical Agent in Moderate to Severe Plaque Psoriasis

Who this might be right for
Psoriasis
Amgen 310
Not applicableStudy completedNCT01726387
What this trial is testing

Self-Management for Anxiety, Depression and Somatoform Disorders

Who this might be right for
Anxiety Depression (Mild or Not Persistent)Major Depressive Disorder, Single Episode, UnspecifiedNeurotic, Stress-related and Somatoform Disorders
Universitätsklinikum Hamburg-Eppendorf 364
Early research (Phase 1)Study completedNCT04067414
What this trial is testing

Exploratory Study of CD19-targeted Chimeric Antigen Receptor T Cells(BZ019) for Relapsed and Refractory B-cell Lymphoma

Who this might be right for
Diffuse Large B Cell LymphomaHigh-grade B-cell LymphomaTransformed Lymphoma+1 more
Institute of Hematology & Blood Diseases Hospital, China 12
Early research (Phase 1)Study completedNCT02924402
What this trial is testing

Study to Evaluate Safety and Tolerability of XmAb13676 (Plamotamab) in Patients With CD20-expressing Hematologic Malignancies

Who this might be right for
B-cell Non-Hodgkins LymphomaChronic Lymphocytic Leukemia
Xencor, Inc. 154
Not applicableLooking for participantsNCT06396312
What this trial is testing

Deep Phenotyping for Clinical Inferring Response in Treatment Resistant Depression

Who this might be right for
Depressive; Disorder, Major, Single Episode, Major, With Psychotic SymptomsDepressive; Disorder, Major, Single Episode, Major (Without Psychotic Symptoms)Depressive Disorder, Major, Recurrent, With Psychotic Symptoms+4 more
Max-Planck-Institute of Psychiatry
Testing effectiveness (Phase 2)Ended earlyNCT02201524
What this trial is testing

Study to Evaluate PF-04965842 in Patients With Moderate to Severe Psoriasis

Who this might be right for
Plaque Psoriasis
Pfizer 59
Not applicableNot Yet RecruitingNCT07463781
What this trial is testing

Neurocognitive Assessment in Adults Undergoing CD19 Targeted CAR-T Cell Therapy

Who this might be right for
Diffuse Large B Cell Lymphoma (DLBCL)High Grade B Cell LymphomaPrimary Mediastinal B-cell Lymphoma (PMBCL)
Fondazione Italiana Linfomi - ETS 100
Next Page
56
130